BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 11111122)

  • 1. Extramedullary progression of multiple myeloma despite concomitant medullary response to multiple combination therapies and autologous transplant: a case report.
    Kumar AK; Dakhil C; Teeka Satyan M; Haideri N
    J Med Case Rep; 2014 Sep; 8():299. PubMed ID: 25200389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive extramedullary disease in myeloma. An uncommon variant with features of poor prognosis and dedifferentiation.
    Sanal SM; Yaylaci M; Mangold KA; Pantazis CG
    Cancer; 1996 Apr; 77(7):1298-302. PubMed ID: 8608506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgD myeloma with multiple cutaneous plasmacytomas.
    Patel K; Carrington PA; Bhatnagar S; Houghton JB; Routledge RC
    Clin Lab Haematol; 1998 Feb; 20(1):53-5. PubMed ID: 9681212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IgD-lambda type multiple myeloma associated with IgG-kappa type benign monoclonal gammopathy].
    Shimada H; Nishinarita S; Kishigami Y; Hayama T; Sawada U; Horie T; Nakamura N; Kato M; Hirano M; Nakamura O
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Apr; 18(2):235-40. PubMed ID: 7553059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
    Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgD multiple myeloma preceding the development of extensive extramedullary disease without medullary involvement.
    Iwasaki T; Hamano T; Ogata A; Hashimoto N; Kakishita E
    Acta Haematol; 2000; 104(1):42-5. PubMed ID: 11111122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic cutaneous plasmacytoma: a case report associated with IgA lambda multiple myeloma and a review of the literature of metastatic cutaneous plasmacytomas associated with multiple myeloma and primary cutaneous plasmacytomas.
    Kato N; Kimura K; Yasukawa K; Aikawa K
    J Dermatol; 1999 Sep; 26(9):587-94. PubMed ID: 10535253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Testicular involvement in IgD multiple myeloma].
    Kawauchi K; Ogasawara T; Yasuyama M; Ohkawa S; Aiba M
    Rinsho Ketsueki; 2001 Nov; 42(11):1128-33. PubMed ID: 11808083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The successful use of natural alpha-interferon single therapy in multiple myeloma of IgD (lambda)-type].
    Suzuki A; Iwase O; Ohkubo T; Nakano M; Toyama K
    Rinsho Ketsueki; 1991 Jan; 32(1):47-51. PubMed ID: 1902271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgD myeloma: clinical, biological and laboratory features.
    Sinclair D
    Clin Lab; 2002; 48(11-12):617-22. PubMed ID: 12465746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia.
    Bladé J; Kyle RA
    Hematol Oncol Clin North Am; 1999 Dec; 13(6):1259-72. PubMed ID: 10626149
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.